Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. NOW
7. GM
8. SMCI
9. IBM
10. EFX

Go back to Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
(NASDAQ: DFTX) Delayed: 43.67 -1.41 (3.13%)
Previous Close $45.08    52 Week High $ 
Open $44.02    52 Week Low $ 
Day High $44.99    P/E N/A 
Day Low $43.53    EPS $ 
Volume 1,239,538